Similar articles

• [For prevention of cardiovascular diseases: statins in old age?].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006 Sep 21;148(38):16. MMW Fortschr Med. 2006. PMID: 17036955 German. No abstract available.
• [Total cardiovascular risk. When is a medication prophylaxis meaningful].

  Einecke D. Einecke D. MMW Fortschr Med. 2003 Oct 30;145(44):6-8. MMW Fortschr Med. 2003. PMID: 14655495 German. No abstract available.
• Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?

  Sherrod JP, Krist A. Sherrod JP, et al. J Fam Pract. 2001 Nov;50(11):928. J Fam Pract. 2001. PMID: 11711006 Review. No abstract available.
• Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

  Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Van Ganse E, et al. Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003. Clin Ther. 2007. PMID: 17919548
• [Obesity and cardiovascular morbidity].

  Berg A, Bönner G. Berg A, et al. Dtsch Med Wochenschr. 2005 Apr 8;130(14):893-7. doi: 10.1055/s-2005-865104. Dtsch Med Wochenschr. 2005. PMID: 15800824 Review. German. No abstract available.